Cycc earnings
WebMar 10, 2024 · CYCC: Cyclacel Pharmaceuticals Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. WebApr 6, 2024 · Cyclacel Pharmaceuticals (CYCC) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... The company reported -$0.6 earnings per share for the quarter, missing the consensus estimate of -$0.482 by -$0.118. Is Cyclacel Pharmaceuticals …
Cycc earnings
Did you know?
WebEdited Transcript of CYCC earnings conference call or presentation 26-Feb-20 9:30pm GMT. Thomson Reuters StreetEvents-11.11%. Feb-26-20 04:05PM: Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results. GlobeNewswire-8.62%. Feb-20-20 08:50AM: WebFeb 24, 2024 · All earnings call transcripts on Cyclacel Pharmaceuticals, Inc. (CYCC) stock. Read or listen to the conference call. Download the investor presentation - earnings call …
WebPer-Share Earnings, Actuals & Estimates Cyclacel Pharmaceuticals Inc. Quarterly. Annual. Actual Analyst Range Consensus. 0.50 0.00 -0.50. Actual -0.42. -0.69. Actual -0.46. -0.54. WebMar 9, 2024 · Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Ensysce Biosciences (NASDAQ:ENSC) are both small-cap medical companies, but which is the superior investment?We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, …
Web4 rows · Mar 31, 2024 · CYCC Cyclacel Pharmaceuticals, Inc.Earnings Date & History. 7.16K followers. $0.59 -0.0062 ( ... WebCyclacel Pharmaceuticals Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CYCC financial statements in full.
WebApr 14, 2024 · The financial services provider reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.02. Commerce Bancshares had a net margin of 31.60% ...
WebGet the latest Cyclacel Pharmaceuticals Inc (CYCC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … ist governo federalWebMar 10, 2024 · Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Rating) last issued its quarterly earnings data on Monday, March 6th.The biotechnology company reported ($0.60) earnings per share (EPS) for the ... igcse business studies past papers cambridgeigcse business studies paper 2 mark schemeWebYou can buy and sell Cyclacel Pharmaceuticals (CYCC) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... CYCC Earnings-$0.68-$0.45-$0.23. $0.00. Q3 FY21. Q4 FY21. Q1 FY22. Q2 FY22. istg production coordinatorWebOct 14, 2024 · CYCC Complete Cyclacel Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Q1 Earnings Insights May. 11, 2024 at 5:17 ... igcse business studies past paperWebApr 14, 2024 · Jefferies Financial Group also issued estimates for Citizens Financial Group’s Q2 2024 earnings at $1.05 EPS, Q3 2024 earnings at $1.04 EPS, Q4 2024 earnings at $1.05 EPS, FY2024 earnings at $4. ... igcse business studies online testWebAug 9, 2024 · Cyclacel Pharmaceuticals (CYCC) is scheduled to announce Q2 earnings results on Tuesday, August 9th, after market close.The consensus EPS Estimate is -$0.67Over the last 3 months,... igcse business studies note